RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Hydrochlorothiazide

edema, hypertension

Indications

  • edema
  • hypertension

Adult dosing

  • edema: dose: 25; unit: mg; route: PO; interval: 25 to 100 mg daily; fixed: true; labelExcerpt: The usual adult dosage is 25 to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week.
  • hypertension: dose: 25; unit: mg; route: PO; interval: 25 to 50 mg daily; fixed: true; labelExcerpt: The usual initial dose in adults is 25 mg daily given as a single dose. The dose may be increased to 50 mg daily, given as a single or two divided doses.

Pediatric dosing

  • diuresis hypertension: dose: 1; unit: mg/kg/day; route: PO; interval: 1-2 mg/kg per day (daily total) in single or two divided doses; label states per-day age-based limits - not a per-dose cap; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: The usual pediatric dosage is 0.5 to 1 mg per pound (1 to 2 mg/kg) per day in single or two divided doses, not to exceed 37.5 mg per day in infants up to 2 years of age or 100 mg per day in children 2 to 12 years of age.

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Use with caution; may precipitate hepatic coma.

Contraindications

  • Anuria
  • Hypersensitivity to hydrochlorothiazide
  • Sulfonamide-derived drug hypersensitivity

Clinical pearls

  • Monitor serum potassium levels; doses above 50 mg are associated with marked reductions.
  • Can cause idiosyncratic acute transient myopia and secondary angle-closure glaucoma.
  • Use caution in patients with renal disease as it may precipitate azotemia.
  • Effectiveness is reduced in patients with severe hepatic or renal dysfunction.

Source and review

  • DailyMed label (hydrochlorothiazide), Set ID 1dc47186-3ecf-456f-b6d6-ba0f75c2504b, effective 2026-11-02. Last reviewed: 2026-11-11